Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository

Plain-language summary

This is a biorepository study that collects biological samples from patients with autosomal dominant polycystic kidney disease (ADPKD) in order to study somatic mutations. It includes patients aged 18 and older with confirmed ADPKD who are undergoing a native nephrectomy (kidney removal). It is being conducted as a study with no assigned phase and enrolls participants by invitation.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Enrolling by invitation

Sponsor

Weill Medical College of Cornell University

Start date

6/1/2018

Estimated completion

12/31/2028

Countries

United States

Related genes

Locations

• New York, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Males or females
* 18 years of age or older
* Confirmed diagnosis of ADPKD
* Undergoing a native nephrectomy
* Willing and able to provide informed consent

Exclusion Criteria:

* Unable or unwilling to provide informed consent